Eisai
4523.T
#1784
Rank
C$13.00 B
Marketcap
$46.13
Share price
0.57%
Change (1 day)
-35.15%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : C$4.53 Billion

According to Eisai's latest financial reports the company's total liabilities are C$4.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31C$4.47 B-6.49%
2022-03-31C$4.78 B15.51%
2021-03-31C$4.14 B-12.2%
2020-03-31C$4.71 B-6.49%
2019-03-31C$5.04 B-4.48%
2018-03-31C$5.28 B3.43%
2017-03-31C$5.10 B11.35%
2016-03-31C$4.58 B-3.86%
2015-03-31C$4.77 B-0.05%
2014-03-31C$4.77 B-14.27%
2013-03-31C$5.56 B-20.51%
2012-03-31C$7.00 B-5.73%
2011-03-31C$7.42 B0.59%
2010-03-31C$7.38 B-19%
2009-03-31C$9.11 B32.51%
2008-03-31C$6.88 B205.15%
2007-03-31C$2.25 B-0.23%
2006-03-31C$2.26 B-1.42%
2005-03-31C$2.29 B-7.06%
2004-03-31C$2.46 B-2.58%
2003-03-31C$2.53 B13.56%
2002-03-31C$2.23 B-12.08%
2001-03-31C$2.53 B